Naturally acquired antibody response to a Plasmodium falciparum chimeric vaccine candidate GMZ2.6c and its components (MSP-3, GLURP, and Pfs48/45) in individuals living in Brazilian malaria-endemic areas
| العنوان: | Naturally acquired antibody response to a Plasmodium falciparum chimeric vaccine candidate GMZ2.6c and its components (MSP-3, GLURP, and Pfs48/45) in individuals living in Brazilian malaria-endemic areas |
|---|---|
| المؤلفون: | Barbara Oliveira Baptista, Ana Beatriz Lopes de Souza, Evelyn Kety Pratt Riccio, Cesare Bianco-Junior, Paulo Renato Rivas Totino, João Hermínio Martins da Silva, Michael Theisen, Susheel Kumar Singh, Linda Eva Amoah, Marcelo Ribeiro-Alves, Rodrigo Medeiros Souza, Josué Costa Lima-Junior, Cláudio Tadeu Daniel-Ribeiro, Lilian Rose Pratt-Riccio |
| المصدر: | Malaria Journal, Vol 21, Iss 1, Pp 1-16 (2022) Baptista, B O, de Souza, A B L, Riccio, E K P, Bianco-Junior, C, Totino, P R R, Martins da Silva, J H, Theisen, M, Singh, S K, Amoah, L E, Ribeiro-Alves, M, Souza, R M, Lima-Junior, J C, Daniel-Ribeiro, C T & Pratt-Riccio, L R 2022, ' Naturally acquired antibody response to a Plasmodium falciparum chimeric vaccine candidate GMZ2.6c and its components (MSP-3, GLURP, and Pfs48/45) in individuals living in Brazilian malaria-endemic areas ', Malaria Journal, vol. 21, pp. 6 . https://doi.org/10.1186/s12936-021-04020-6 Malaria Journal |
| بيانات النشر: | BMC, 2022. |
| سنة النشر: | 2022 |
| مصطلحات موضوعية: | Adult, Male, Adolescent, Plasmodium falciparum, RC955-962, Protozoan Proteins, Antigens, Protozoan, Infectious and parasitic diseases, RC109-216, Antibodies, Young Adult, Arctic medicine. Tropical medicine, Malaria Vaccines, parasitic diseases, Humans, Immune response, Membrane Glycoproteins, Research, GMZ2.6c, Middle Aged, Peptide Fragments, Malaria, Infectious Diseases, Antibody Formation, Female, Parasitology, Vaccine, Brazil |
| الوصف: | BackgroundThe GMZ2.6c malaria vaccine candidate is a multi-stagePlasmodium falciparumchimeric protein which contains a fragment of the sexual-stage Pfs48/45-6C protein genetically fused to GMZ2, a fusion protein of GLURP and MSP-3, that has been shown to be well tolerated, safe and immunogenic in clinical trials performed in a malaria-endemic area of Africa. However, there is no data available on the antigenicity or immunogenicity of GMZ2.6c in humans. Considering that circulating parasites can be genetically distinct in different malaria-endemic areas and that host genetic factors can influence the immune response to vaccine antigens, it is important to verify the antigenicity, immunogenicity and the possibility of associated protection in individuals living in malaria-endemic areas with different epidemiological scenarios. Herein, the profile of antibody response against GMZ2.6c and its components (MSP-3, GLURP and Pfs48/45) in residents of the Brazilian Amazon naturally exposed to malaria, in areas with different levels of transmission, was evaluated.MethodsThis study was performed using serum samples from 352 individuals from Cruzeiro do Sul and Mâncio Lima, in the state of Acre, and Guajará, in the state of Amazonas. Specific IgG, IgM, IgA and IgE antibodies and IgG subclasses were detected by Enzyme-Linked Immunosorbent Assay.ResultsThe results showed that GMZ2.6c protein was widely recognized by naturally acquired antibodies from individuals of the Brazilian endemic areas with different levels of transmission. The higher prevalence of individuals with antibodies against GMZ2.6c when compared to its individual components may suggest an additive effect of GLURP, MSP-3, and Pfs48/45 when inserted in a same construct. Furthermore, naturally malaria-exposed individuals predominantly had IgG1 and IgG3 cytophilic anti-GMZ2.6c antibodies, an important fact considering that the acquisition of anti-malaria protective immunity results from a delicate balance between cytophilic/non-cytophilic antibodies. Interestingly, anti-GMZ2.6c antibodies seem to increase with exposure to malaria infection and may contribute to parasite immunity.ConclusionsThe data showed that GMZ2.6c protein is widely recognized by naturally acquired antibodies from individuals living in malaria-endemic areas in Brazil and that these may contribute to parasite immunity. These data highlight the importance of GMZ2.6c as a candidate for an anti-malarial vaccine. |
| وصف الملف: | application/pdf |
| اللغة: | English |
| تدمد: | 1475-2875 |
| DOI: | 10.1186/s12936-021-04020-6 |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a33ef6ab4982265ef94a144e36f9889 https://doaj.org/article/1c53bedbb908417a9a9a4057adf02661 |
| Rights: | OPEN |
| رقم الانضمام: | edsair.doi.dedup.....5a33ef6ab4982265ef94a144e36f9889 |
| قاعدة البيانات: | OpenAIRE |
| ResultId |
1 |
|---|---|
| Header |
edsair OpenAIRE edsair.doi.dedup.....5a33ef6ab4982265ef94a144e36f9889 890 3 unknown 889.59912109375 |
| PLink |
https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....5a33ef6ab4982265ef94a144e36f9889&custid=s6537998&authtype=sso |
| FullText |
Array
(
[Availability] => 0
)
Array ( [0] => Array ( [Url] => https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a33ef6ab4982265ef94a144e36f9889# [Name] => EDS - OpenAIRE [Category] => fullText [Text] => View record in OpenAIRE [MouseOverText] => View record in OpenAIRE ) ) |
| Items |
Array
(
[Name] => Title
[Label] => Title
[Group] => Ti
[Data] => Naturally acquired antibody response to a Plasmodium falciparum chimeric vaccine candidate GMZ2.6c and its components (MSP-3, GLURP, and Pfs48/45) in individuals living in Brazilian malaria-endemic areas
)
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22Barbara+Oliveira+Baptista%22">Barbara Oliveira Baptista</searchLink><br /><searchLink fieldCode="AR" term="%22Ana+Beatriz+Lopes+de+Souza%22">Ana Beatriz Lopes de Souza</searchLink><br /><searchLink fieldCode="AR" term="%22Evelyn+Kety+Pratt+Riccio%22">Evelyn Kety Pratt Riccio</searchLink><br /><searchLink fieldCode="AR" term="%22Cesare+Bianco-Junior%22">Cesare Bianco-Junior</searchLink><br /><searchLink fieldCode="AR" term="%22Paulo+Renato+Rivas+Totino%22">Paulo Renato Rivas Totino</searchLink><br /><searchLink fieldCode="AR" term="%22João+Hermínio+Martins+da+Silva%22">João Hermínio Martins da Silva</searchLink><br /><searchLink fieldCode="AR" term="%22Michael+Theisen%22">Michael Theisen</searchLink><br /><searchLink fieldCode="AR" term="%22Susheel+Kumar+Singh%22">Susheel Kumar Singh</searchLink><br /><searchLink fieldCode="AR" term="%22Linda+Eva+Amoah%22">Linda Eva Amoah</searchLink><br /><searchLink fieldCode="AR" term="%22Marcelo+Ribeiro-Alves%22">Marcelo Ribeiro-Alves</searchLink><br /><searchLink fieldCode="AR" term="%22Rodrigo+Medeiros+Souza%22">Rodrigo Medeiros Souza</searchLink><br /><searchLink fieldCode="AR" term="%22Josué+Costa+Lima-Junior%22">Josué Costa Lima-Junior</searchLink><br /><searchLink fieldCode="AR" term="%22Cláudio+Tadeu+Daniel-Ribeiro%22">Cláudio Tadeu Daniel-Ribeiro</searchLink><br /><searchLink fieldCode="AR" term="%22Lilian+Rose+Pratt-Riccio%22">Lilian Rose Pratt-Riccio</searchLink> ) Array ( [Name] => TitleSource [Label] => Source [Group] => Src [Data] => Malaria Journal, Vol 21, Iss 1, Pp 1-16 (2022)<br />Baptista, B O, de Souza, A B L, Riccio, E K P, Bianco-Junior, C, Totino, P R R, Martins da Silva, J H, Theisen, M, Singh, S K, Amoah, L E, Ribeiro-Alves, M, Souza, R M, Lima-Junior, J C, Daniel-Ribeiro, C T & Pratt-Riccio, L R 2022, ' Naturally acquired antibody response to a Plasmodium falciparum chimeric vaccine candidate GMZ2.6c and its components (MSP-3, GLURP, and Pfs48/45) in individuals living in Brazilian malaria-endemic areas ', Malaria Journal, vol. 21, pp. 6 . https://doi.org/10.1186/s12936-021-04020-6<br />Malaria Journal ) Array ( [Name] => Publisher [Label] => Publisher Information [Group] => PubInfo [Data] => BMC, 2022. ) Array ( [Name] => DatePubCY [Label] => Publication Year [Group] => Date [Data] => 2022 ) Array ( [Name] => Subject [Label] => Subject Terms [Group] => Su [Data] => <searchLink fieldCode="DE" term="%22Adult%22">Adult</searchLink><br /><searchLink fieldCode="DE" term="%22Male%22">Male</searchLink><br /><searchLink fieldCode="DE" term="%22Adolescent%22">Adolescent</searchLink><br /><searchLink fieldCode="DE" term="%22Plasmodium+falciparum%22">Plasmodium falciparum</searchLink><br /><searchLink fieldCode="DE" term="%22RC955-962%22">RC955-962</searchLink><br /><searchLink fieldCode="DE" term="%22Protozoan+Proteins%22">Protozoan Proteins</searchLink><br /><searchLink fieldCode="DE" term="%22Antigens%2C+Protozoan%22">Antigens, Protozoan</searchLink><br /><searchLink fieldCode="DE" term="%22Infectious+and+parasitic+diseases%22">Infectious and parasitic diseases</searchLink><br /><searchLink fieldCode="DE" term="%22RC109-216%22">RC109-216</searchLink><br /><searchLink fieldCode="DE" term="%22Antibodies%22">Antibodies</searchLink><br /><searchLink fieldCode="DE" term="%22Young+Adult%22">Young Adult</searchLink><br /><searchLink fieldCode="DE" term="%22Arctic+medicine%2E+Tropical+medicine%22">Arctic medicine. Tropical medicine</searchLink><br /><searchLink fieldCode="DE" term="%22Malaria+Vaccines%22">Malaria Vaccines</searchLink><br /><searchLink fieldCode="DE" term="%22parasitic+diseases%22">parasitic diseases</searchLink><br /><searchLink fieldCode="DE" term="%22Humans%22">Humans</searchLink><br /><searchLink fieldCode="DE" term="%22Immune+response%22">Immune response</searchLink><br /><searchLink fieldCode="DE" term="%22Membrane+Glycoproteins%22">Membrane Glycoproteins</searchLink><br /><searchLink fieldCode="DE" term="%22Research%22">Research</searchLink><br /><searchLink fieldCode="DE" term="%22GMZ2%2E6c%22">GMZ2.6c</searchLink><br /><searchLink fieldCode="DE" term="%22Middle+Aged%22">Middle Aged</searchLink><br /><searchLink fieldCode="DE" term="%22Peptide+Fragments%22">Peptide Fragments</searchLink><br /><searchLink fieldCode="DE" term="%22Malaria%22">Malaria</searchLink><br /><searchLink fieldCode="DE" term="%22Infectious+Diseases%22">Infectious Diseases</searchLink><br /><searchLink fieldCode="DE" term="%22Antibody+Formation%22">Antibody Formation</searchLink><br /><searchLink fieldCode="DE" term="%22Female%22">Female</searchLink><br /><searchLink fieldCode="DE" term="%22Parasitology%22">Parasitology</searchLink><br /><searchLink fieldCode="DE" term="%22Vaccine%22">Vaccine</searchLink><br /><searchLink fieldCode="DE" term="%22Brazil%22">Brazil</searchLink> ) Array ( [Name] => Abstract [Label] => Description [Group] => Ab [Data] => BackgroundThe GMZ2.6c malaria vaccine candidate is a multi-stagePlasmodium falciparumchimeric protein which contains a fragment of the sexual-stage Pfs48/45-6C protein genetically fused to GMZ2, a fusion protein of GLURP and MSP-3, that has been shown to be well tolerated, safe and immunogenic in clinical trials performed in a malaria-endemic area of Africa. However, there is no data available on the antigenicity or immunogenicity of GMZ2.6c in humans. Considering that circulating parasites can be genetically distinct in different malaria-endemic areas and that host genetic factors can influence the immune response to vaccine antigens, it is important to verify the antigenicity, immunogenicity and the possibility of associated protection in individuals living in malaria-endemic areas with different epidemiological scenarios. Herein, the profile of antibody response against GMZ2.6c and its components (MSP-3, GLURP and Pfs48/45) in residents of the Brazilian Amazon naturally exposed to malaria, in areas with different levels of transmission, was evaluated.MethodsThis study was performed using serum samples from 352 individuals from Cruzeiro do Sul and Mâncio Lima, in the state of Acre, and Guajará, in the state of Amazonas. Specific IgG, IgM, IgA and IgE antibodies and IgG subclasses were detected by Enzyme-Linked Immunosorbent Assay.ResultsThe results showed that GMZ2.6c protein was widely recognized by naturally acquired antibodies from individuals of the Brazilian endemic areas with different levels of transmission. The higher prevalence of individuals with antibodies against GMZ2.6c when compared to its individual components may suggest an additive effect of GLURP, MSP-3, and Pfs48/45 when inserted in a same construct. Furthermore, naturally malaria-exposed individuals predominantly had IgG1 and IgG3 cytophilic anti-GMZ2.6c antibodies, an important fact considering that the acquisition of anti-malaria protective immunity results from a delicate balance between cytophilic/non-cytophilic antibodies. Interestingly, anti-GMZ2.6c antibodies seem to increase with exposure to malaria infection and may contribute to parasite immunity.ConclusionsThe data showed that GMZ2.6c protein is widely recognized by naturally acquired antibodies from individuals living in malaria-endemic areas in Brazil and that these may contribute to parasite immunity. These data highlight the importance of GMZ2.6c as a candidate for an anti-malarial vaccine. ) Array ( [Name] => Format [Label] => File Description [Group] => SrcInfo [Data] => application/pdf ) Array ( [Name] => Language [Label] => Language [Group] => Lang [Data] => English ) Array ( [Name] => ISSN [Label] => ISSN [Group] => ISSN [Data] => 1475-2875 ) Array ( [Name] => DOI [Label] => DOI [Group] => ID [Data] => 10.1186/s12936-021-04020-6 ) Array ( [Name] => URL [Label] => Access URL [Group] => URL [Data] => <link linkTarget="URL" linkTerm="https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a33ef6ab4982265ef94a144e36f9889" linkWindow="_blank">https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a33ef6ab4982265ef94a144e36f9889</link><br /><link linkTarget="URL" linkTerm="https://doaj.org/article/1c53bedbb908417a9a9a4057adf02661" linkWindow="_blank">https://doaj.org/article/1c53bedbb908417a9a9a4057adf02661</link> ) Array ( [Name] => Copyright [Label] => Rights [Group] => Cpyrght [Data] => OPEN ) Array ( [Name] => AN [Label] => Accession Number [Group] => ID [Data] => edsair.doi.dedup.....5a33ef6ab4982265ef94a144e36f9889 ) |
| RecordInfo |
Array
(
[BibEntity] => Array
(
[Identifiers] => Array
(
[0] => Array
(
[Type] => doi
[Value] => 10.1186/s12936-021-04020-6
)
)
[Languages] => Array
(
[0] => Array
(
[Text] => English
)
)
[PhysicalDescription] => Array
(
[Pagination] => Array
(
[PageCount] => 16
[StartPage] => 1
)
)
[Subjects] => Array
(
[0] => Array
(
[SubjectFull] => Adult
[Type] => general
)
[1] => Array
(
[SubjectFull] => Male
[Type] => general
)
[2] => Array
(
[SubjectFull] => Adolescent
[Type] => general
)
[3] => Array
(
[SubjectFull] => Plasmodium falciparum
[Type] => general
)
[4] => Array
(
[SubjectFull] => RC955-962
[Type] => general
)
[5] => Array
(
[SubjectFull] => Protozoan Proteins
[Type] => general
)
[6] => Array
(
[SubjectFull] => Antigens, Protozoan
[Type] => general
)
[7] => Array
(
[SubjectFull] => Infectious and parasitic diseases
[Type] => general
)
[8] => Array
(
[SubjectFull] => RC109-216
[Type] => general
)
[9] => Array
(
[SubjectFull] => Antibodies
[Type] => general
)
[10] => Array
(
[SubjectFull] => Young Adult
[Type] => general
)
[11] => Array
(
[SubjectFull] => Arctic medicine. Tropical medicine
[Type] => general
)
[12] => Array
(
[SubjectFull] => Malaria Vaccines
[Type] => general
)
[13] => Array
(
[SubjectFull] => parasitic diseases
[Type] => general
)
[14] => Array
(
[SubjectFull] => Humans
[Type] => general
)
[15] => Array
(
[SubjectFull] => Immune response
[Type] => general
)
[16] => Array
(
[SubjectFull] => Membrane Glycoproteins
[Type] => general
)
[17] => Array
(
[SubjectFull] => Research
[Type] => general
)
[18] => Array
(
[SubjectFull] => GMZ2.6c
[Type] => general
)
[19] => Array
(
[SubjectFull] => Middle Aged
[Type] => general
)
[20] => Array
(
[SubjectFull] => Peptide Fragments
[Type] => general
)
[21] => Array
(
[SubjectFull] => Malaria
[Type] => general
)
[22] => Array
(
[SubjectFull] => Infectious Diseases
[Type] => general
)
[23] => Array
(
[SubjectFull] => Antibody Formation
[Type] => general
)
[24] => Array
(
[SubjectFull] => Female
[Type] => general
)
[25] => Array
(
[SubjectFull] => Parasitology
[Type] => general
)
[26] => Array
(
[SubjectFull] => Vaccine
[Type] => general
)
[27] => Array
(
[SubjectFull] => Brazil
[Type] => general
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => Naturally acquired antibody response to a Plasmodium falciparum chimeric vaccine candidate GMZ2.6c and its components (MSP-3, GLURP, and Pfs48/45) in individuals living in Brazilian malaria-endemic areas
[Type] => main
)
)
)
[BibRelationships] => Array
(
[HasContributorRelationships] => Array
(
[0] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Barbara Oliveira Baptista
)
)
)
[1] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Ana Beatriz Lopes de Souza
)
)
)
[2] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Evelyn Kety Pratt Riccio
)
)
)
[3] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Cesare Bianco-Junior
)
)
)
[4] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Paulo Renato Rivas Totino
)
)
)
[5] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => João Hermínio Martins da Silva
)
)
)
[6] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Michael Theisen
)
)
)
[7] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Susheel Kumar Singh
)
)
)
[8] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Linda Eva Amoah
)
)
)
[9] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Marcelo Ribeiro-Alves
)
)
)
[10] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Rodrigo Medeiros Souza
)
)
)
[11] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Josué Costa Lima-Junior
)
)
)
[12] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Cláudio Tadeu Daniel-Ribeiro
)
)
)
[13] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Lilian Rose Pratt-Riccio
)
)
)
)
[IsPartOfRelationships] => Array
(
[0] => Array
(
[BibEntity] => Array
(
[Dates] => Array
(
[0] => Array
(
[D] => 01
[M] => 01
[Type] => published
[Y] => 2022
)
)
[Identifiers] => Array
(
[0] => Array
(
[Type] => issn-print
[Value] => 14752875
)
[1] => Array
(
[Type] => issn-locals
[Value] => edsair
)
[2] => Array
(
[Type] => issn-locals
[Value] => edsairFT
)
)
[Numbering] => Array
(
[0] => Array
(
[Type] => volume
[Value] => 21
)
[1] => Array
(
[Type] => issue
[Value] => 1
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => Malaria Journal
[Type] => main
)
)
)
)
)
)
)
|
| IllustrationInfo |